Novel intermediate for the synthesis of prostaglandins

An enantiomerically enriched compound of formula (1), wherein Ar is phenyl optionally substituted with one or more groups selected from haloalkyl, alkyl and halide. This compound can be isolated in crystalline form, and used in the preparation of (+)-16-[3-trifluoromethyl)phenoxy]-17, 18, 19, 20-tet...

Full description

Saved in:
Bibliographic Details
Main Authors LENNON IAN CAMPBELL, JACKSON PHILIP MARK
Format Patent
LanguageEnglish
Hungarian
Published 28.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An enantiomerically enriched compound of formula (1), wherein Ar is phenyl optionally substituted with one or more groups selected from haloalkyl, alkyl and halide. This compound can be isolated in crystalline form, and used in the preparation of (+)-16-[3-trifluoromethyl)phenoxy]-17, 18, 19, 20-tetranor PGF2 alpha isopropyl ester.
Bibliography:Application Number: HUP0200746